TARO PHARMACEUTICAL INDS LTD - SHS (TARO)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / SHS
Shares, excl. options Q2 2024
680K
Holdings value Q2 2024
$29.2M
Value change Q2 2024
-$167M
Grand Portfolio weight change Q2 2024
0%
Number of holders
15
Number of buys Q2 2024
10
Number of sells Q2 2024
-81
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 76 $3.27K $0 $42.97 1
2024 Q2 680K $29.2M -$167M $42.97 15
2024 Q1 4.65M $197M -$8.41M $42.34 91
2023 Q4 4.85M $203M +$431K $41.78 86
2023 Q3 4.85M $183M +$975K $37.71 80
2023 Q2 4.73M $179M +$27.6M $37.93 69
2023 Q1 4.15M $101M -$1.45M $24.32 59
2022 Q4 4.19M $122M -$4.7M $29.04 56
2022 Q3 4.34M $130M -$387K $29.98 59
2022 Q2 4.32M $156M -$6.61M $36.16 67
2022 Q1 4.54M $197M -$3.29M $43.26 60
2021 Q4 4.62M $231M -$729K $50.11 67
2021 Q3 4.61M $294M -$10.1M $63.63 69
2021 Q2 4.76M $343M -$12.8M $71.96 74
2021 Q1 4.84M $357M -$13.7M $73.75 78
2020 Q4 5.03M $369M +$21M $73.42 82
2020 Q3 4.79M $262M +$1.58M $54.85 76
2020 Q2 4.75M $315M +$9.01M $66.49 82
2020 Q1 4.62M $283M +$6.67M $61.20 87
2019 Q4 4.4M $385M +$18.2M $87.93 93
2019 Q3 4.22M $317M +$7.26M $75.45 98
2019 Q2 4.12M $350M +$656K $85.42 102
2019 Q1 4.09M $439M +$16.2M $108.09 100
2018 Q4 3.95M $332M -$38M $84.64 90
2018 Q3 4.31M $420M -$5.29M $98.30 110
2018 Q2 4.33M $495M -$20.4M $115.69 105
2018 Q1 4.53M $444M -$47.2M $98.74 107
2017 Q4 5.01M $521M -$77.7M $104.71 123
2017 Q3 5.62M $633M -$40.7M $112.69 131
2017 Q2 5.98M $670M -$19.7M $112.06 136
2017 Q1 6.04M $707M -$34.8M $116.62 132
2016 Q4 6.83M $717M -$57M $105.27 147
2016 Q3 7.48M $828M +$43.2M $110.51 159
2016 Q2 6.9M $1.01B +$176M $145.60 155
2016 Q1 5.75M $822M -$7.54M $143.25 164
2015 Q4 5.8M $896M +$125M $154.55 150
2015 Q3 4.89M $698M +$22.2M $142.89 115
2015 Q2 4.73M $680M -$38.7M $143.69 101
2015 Q1 4.96M $701M -$20.6M $141.03 95
2014 Q4 5.33M $791M -$25.3M $148.19 89
2014 Q3 4.55M $700M -$27.9M $153.86 80
2014 Q2 4.74M $664M +$98.4M $140.24 72
2014 Q1 4.04M $449M -$14.1M $111.00 65